CoChat

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

Open access
Holroyd, Christopher R, Seth, Rakhi, Bukhari, Marwan, Malaviya, Anshuman, Holmes, Claire, Curtis, Elizabeth, Chan, Christopher, Yusuf, Mohammed A, Litwic, Anna, Smolen, Susan, Topliffe, Joanne, Bennett, Sarah, Humphreys, Jennifer, Green, Muriel, Ledingham, Jo · 2019 · Rheumatology
Cited by 183

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

The use of biologic therapies has transformed the management of inflammatory arthritis (IA). In contrast to conventional systemic DMARDs (csDMARDs) traditionally used to treat inflammatory disease, these agents offer a targeted approach, and their widespread use has resulted in disease remission becoming an increasingly achievable goal. Biologic therapies are not without potential risk, and hence it is important that clinicians are aware of these risks and ensure that appropriate precautions are taken to minimize them. Information on the safety of biologic therapies continues to be collected through national registries, clinical and cohort studies and case series and reports. NICE has accredited the process used by the BSR to produce its guidance on the safety of biologic DMARDs in inflammatory arthritis. Accreditation is valid for 5 years from 10 June 2013 This guideline supersedes the previous BSR/BHPR anti-TNF [1], rituximab (RTX) [2] and tocilizumab (TCZ) [3] guidelines and has been developed in line with the BSR Guidelines Protocol.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/rheumatology/key208

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 183

Metadata

Authors
Holroyd, C. R., Seth, R., Bukhari, M., Malaviya, A., Holmes, C., Curtis, E., Chan, C., Yusuf, M. A., Litwic, A., Smolen, S., Topliffe, J., Bennett, S., Humphreys, J., Green, M., & Ledingham, J.
Venue
Rheumatology
Published
2018-08-21
Volume
58
Issue
2
Pages
e3-e42
ISSN
  • 1462-0324 (ISSN-L)
  • 1462-0332
OpenAlex
W2888212400
Cited by
183
References
11
FWCI
9.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. https://app.cochat.ai/papers/10.1093/rheumatology/key208
The paper
Holroyd, C. R., Seth, R., Bukhari, M., Malaviya, A., Holmes, C., Curtis, E., Chan, C., Yusuf, M. A., Litwic, A., Smolen, S., Topliffe, J., Bennett, S., Humphreys, J., Green, M., & Ledingham, J. (2019). The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Rheumatology. https://doi.org/10.1093/rheumatology/key208

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.